IOM Releases New Report on Childhood Immunization Schedule and Safety
Centers for Disease Control and Prevention (CDC) sent this bulletin at 01/17/2013 11:29 AM ESTIOM Releases New Report on Childhood Immunization Schedule and Safety
At the request of the Department of Health & Human Services’ (HHS) National Vaccine Program Office (NVPO) and CDC, the Institute of Medicine (IOM) convened a special committee to conduct an independent evaluation of studying the safety of the childhood immunization schedule.
The IOM Committee was asked to:
- Review scientific findings and stakeholder concerns about the safety of the current schedule.
- Identify potential research approaches, methodologies and study designs for safety studies, as well as the financial and ethical feasibility of doing them.
- Issue a report of its findings.
The IOM Committee found no evidence of major safety concerns with adherence to the current childhood vaccination schedule. The Committee also recommended using existing healthcare records data to continue to study the safety of U.S. licensed childhood vaccines.
The full IOM Report is available at http://www.iom.edu/Reports/2013/The-Childhood-Immunization-Schedule-and-Safety.aspx.
Additional information about the IOM assessment can be found at http://www.iom.edu/Activities/PublicHealth/ChildhoodImmunization.aspx.
The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies, a new report from the Institute of Medicine, examines evidence about the schedule's safety and recommends the best way to conduct any needed investigations. Members of the committee that wrote the report will discuss their conclusions and recommendations during a one-hour telephone briefing starting at 11 a.m. EST Wednesday, Jan. 16.
DETAILS:
To join the telephone briefing, please dial: 312-470-7421. The passcode is "immunization."
The report will be available at 11 a.m. EST today at www.iom.edu/childimmunizationschedule. Questions or comments can be directed to the study’s email address, HealthOutcomes@nas.edu.
The IOM will conduct an independent assessment surrounding the feasibility of studying health outcomes in children who were vaccinated according to the CDC recommended schedule and those who were not (e.g. children who were unvaccinated or vaccinated with an alternate schedule). The IOM will review scientific findings and stakeholder concerns related to the safety of the recommended childhood immunization schedule. Further, the IOM will identify potential research approaches, methodologies, and study designs that could inform this question, including an assessment of the potential strengths and limitations of each approach, methodology and design, as well as the financial and ethical feasibility of doing them. A report will be issued in mid-2012 summarizing the IOM's findings and conclusions.
Public Comment: If you have information you would like to share with the committee, you may do so by submitting your comment to the project email at healthoutcomes@nas.edu. Please note that any comments that you submit to the committee using this email address or otherwise, including your name and identifying information, will not be kept confidential and will be included in a Public Access File in compliance with Section 15 of the Federal Advisory Committee Act (FACA). The National Academies shall be authorized to use any such comments or submissions in accordance with the National Academies' Terms of Use Statement.
For more information
Report
Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies
- Released:
- January 16, 2013
- Type:
- Consensus Report
- Topics:
- Biomedical and Health Research, Children, Youth and Families, Public Health
- Activity:
- Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule
- Board:
- Board on Population Health and Public Health Practice
Vaccines are among the most safe and effective public health interventions to prevent serious disease and death. Because of the success of vaccines, most Americans today have no firsthand experience with such devastating illnesses as polio or diphtheria. Health care providers who vaccinate young children follow a schedule prepared by the U.S. Advisory Committee on Immunization Practices. Under the current schedule, children younger than six may receive as many as 24 immunizations by their second birthday. New vaccines undergo rigorous testing prior to receiving FDA approval; however, like all medicines and medical interventions, vaccines carry some risk. Driven largely by concerns about potential side effects, there has been a shift in some parents’ attitudes toward the child immunization schedule. HHS asked the IOM to identify research approaches, methodologies, and study designs that could address questions about the safety of the current schedule.
This report is the most comprehensive examination of the immunization schedule to date. The IOM committee uncovered no evidence of major safety concerns associated with adherence to the childhood immunization schedule. Should signals arise that there may be need for investigation, however, the report offers a framework for conducting safety research using existing or new data collection systems.
This report is the most comprehensive examination of the immunization schedule to date. The IOM committee uncovered no evidence of major safety concerns associated with adherence to the childhood immunization schedule. Should signals arise that there may be need for investigation, however, the report offers a framework for conducting safety research using existing or new data collection systems.
Activity
Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule
Activity Description
Report ReleaseThe Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies, a new report from the Institute of Medicine, examines evidence about the schedule's safety and recommends the best way to conduct any needed investigations. Members of the committee that wrote the report will discuss their conclusions and recommendations during a one-hour telephone briefing starting at 11 a.m. EST Wednesday, Jan. 16.
DETAILS:
To join the telephone briefing, please dial: 312-470-7421. The passcode is "immunization."
The report will be available at 11 a.m. EST today at www.iom.edu/childimmunizationschedule. Questions or comments can be directed to the study’s email address, HealthOutcomes@nas.edu.
The IOM will conduct an independent assessment surrounding the feasibility of studying health outcomes in children who were vaccinated according to the CDC recommended schedule and those who were not (e.g. children who were unvaccinated or vaccinated with an alternate schedule). The IOM will review scientific findings and stakeholder concerns related to the safety of the recommended childhood immunization schedule. Further, the IOM will identify potential research approaches, methodologies, and study designs that could inform this question, including an assessment of the potential strengths and limitations of each approach, methodology and design, as well as the financial and ethical feasibility of doing them. A report will be issued in mid-2012 summarizing the IOM's findings and conclusions.
Public Comment: If you have information you would like to share with the committee, you may do so by submitting your comment to the project email at healthoutcomes@nas.edu. Please note that any comments that you submit to the committee using this email address or otherwise, including your name and identifying information, will not be kept confidential and will be included in a Public Access File in compliance with Section 15 of the Federal Advisory Committee Act (FACA). The National Academies shall be authorized to use any such comments or submissions in accordance with the National Academies' Terms of Use Statement.
For more information
No hay comentarios:
Publicar un comentario